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ABSTRACT
Background and Objectives: We used virtual histology-intravascular ultrasound (VH-IVUS) to evaluate the relationship be-
tween high-sensitivity C-reactive protein (hs-CRP) levels and plaque components in 279 acute coronary syndrome (ACS) pa-
tients. Subjects and Methods: We divided patients into three groups according to their hs-CRP levels {lowest tertile <0.07 
mg/dL (n=93), middle tertile ≥0.07, <0.4 mg/dL (n=93), and highest tertile ≥0.4 mg/dL (n=93)}. Thin-cap fibroatheroma 
(TCFA) was defined as focal, necrotic core (NC)-rich (≥10% of the cross-sectional area) plaques in contact with the lumen in a 
plaque burden ≥40%. Results: The highest tertile group was mostly diabetics (20%, 27%, 40%, p=0.009), and had the greatest 
plaque plus media volume (163±139/mm
3 vs. 201±155/mm
3 vs. 232±176/mm
3, p=0.013). The highest tertile group had the 
greatest absolute and % NC volumes (13.6±15.1 mm
3 vs. 14.8±14.2 mm
3 vs. 23.7±24.3 mm
3, p<0.001, and 14.9±8.7% vs. 
16.0±8.7% vs. 19.5±10.2%, p=0.024, respectively). The culprit lesion TCFA was observed most frequently in the highest ter-
tile group (28% vs. 35% vs. 55%, p=0.006). By multivariable analysis, absolute NC volume was an independent predictor of hs-
CRP elevation {odds ratio (OR); 1.03, 95% confidence interval (CI)=1.06-1.21, p=0.004}, and hs-CRP was an independent pre-
dictor of TCFA (OR; 1.86, 95% CI=1.11-2.90, p=0.010). Conclusion: VH-IVUS analysis has demonstrated that ACS patients 
with elevated hs-CRP have more vulnerable plaque component (NC-rich plaques and higher frequency of culprit lesion 
TCFA), compared with ACS patients with normal hs-CRP. (Korean Circ J 2011;41:440-446)
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Introduction
Vascular inflammation plays a pivotal role in atherogenesis 
and thrombotic events.
1) High-sensitivity C-reactive protein 
(hs-CRP) has been associated with metabolic syndrome
2) and 
with elevated risks for the development of coronary artery 
disease.
3) hs-CRP has emerged as a simple tool for detecting 
systemic inflammation in patients with subsequent coronary 
events.
4) Measurement of hs-CRP has been recommended for 
patients to refine risk assessment.
5) 
Several grey-scale intravascular ultrasound (IVUS) studies 
have demonstrated increased incidence of culprit-lesion pla-
que rupture in patients with acute coronary syndrome (ACS).
6-8) 
There is a strong inflammatory response to tissue injury that 
occurs during ACS, and plaque rupture and the extent of in-
flammatory response may be an important determinant of 
clinical outcome.
9) Several studies have reported that CRP 
elevation was associated with culprit lesion plaque rupture 
in ACS patients.
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IVUS studies have demonstrated coronary plaque compon-
ents in ACS patients.
11)12)
In spite of the strong association between CRP levels and 
vulnerable plaque using grey-scale IVUS, no studies have de-
monstrated a relationship between inflammatory response 
indicated by CRP, and plaque characteristics in ACS pa-
tients. Therefore, the aim of this study was to assess the rela-
tionship between hs-CRP levels and plaque characteristics, 
including plaque composition, and the incidence of thin-cap 
fibroatheroma (TCFA) in ACS patients.
Subjects and Methods
Patient population
This study was a retrospective, single-center study. From 
July 2007 to June 2008, 279 consecutive ACS patients who un-
derwent VH-IVUS for native, de novo coronary lesions and 
underwent pre-procedural hs-CRP evaluation were includ-
ed in this study. We divided patients into three groups ac-
cording to their pre-procedural hs-CRP levels {lowest tertile 
<0.07 mg/dL (n=93), middle tertile ≥0.07, <0.4 mg/dL (n= 
93), and highest tertile >0.4 mg/dL (n=93)}. The presence of 
unstable angina was determined by chest pain within the 
preceding 72 hours with or without ST-T-wave changes, or 
positive cardiac biochemical markers (creatine kinase-myo-
cardial band or cardiac specific troponin-I). The presence of 
ST-segment elevation myocardial infarction was determined 
by >30 minutes of continuous chest pain, new ST-segment 
elevation ≥2 mm on at least 2 contiguous electrocardiogra-
phic leads, and creatine kinase-MB (CK-MB) >3 times the 
normal limit. The presence of non-ST-segment elevation myo-
cardial infarction was diagnosed by chest pain, and positive 
cardiac biochemical markers (creatine kinase-myocardial 
band or cardiac specific troponin-I) without new ST-segment 
elevation. The protocol was approved by the institutional re-
view board. Hospital records of patients were reviewed to ob-
tain information on clinical demographics.
Laboratory analysis 
Venous blood samples were obtained before the IVUS st-
udy within 24 hours of symptom onset. Blood samples were 
centrifuged, and serum was removed and stored at -70°C 
until the assay could be performed. hs-CRP was assessed by 
the immunoturbidimetric CRP-Latex (II) hs assay using an 
Olympus 5431 autoanalyzer. The assay was performed ac-
cording to the manufacturer’s protocol, and has been vali-
dated against the Dade-Behring method.
13) This assay has a 
coefficient of variation of 5%. Serum N-terminal pro-B-type 
natriuretic peptide was measured using an electrochemilu-
minescence sandwich immunoassay method with an Elecsys 
2010 analyzer (Roche Diagnostics, Mannheim, Germany). 
Absolute CK-MB levels were determined by radioimmuno-
assay (Dade Behring Inc., Miami, FL, USA). Cardiac-specif-
ic troponin I levels were measured by paramagnetic particle, 
chemiluminescent immunoenzymatic assay (Beckman, Co-
ulter Inc., Fullerton, CA, USA). The serum levels of total cho-
lesterol, triglyceride, low-density lipoprotein-cholesterol (LDL-
C), and high-density lipoprotein cholesterol were measured 
by standard enzymatic methods. 
Angiographic analysis
Coronary angiogram was analyzed with a validated quan-
titative coronary angiography (QCA) system (Phillips H5000 
or Allura DCI program, Philips Medical Systems, Eindho-
ven, the Netherlands). The outer diameter of the contrast-
filled catheter was the calibration standard. Minimal lumen 
and reference diameters were measured in diastolic frames 
from orthogonal projections. 
Intravascular ultrasound imaging and analysis 
All pre-intervention grey-scale and VH-IVUS examina-
tions were performed after intracoronary administration of 
300 μg nitroglycerin. A 20-MHz, 2.9F IVUS imaging cathe-
ter (Eagle Eye, Volcano Corp, Rancho Cordova, CA, USA) was 
advanced >10 mm beyond the lesion. Automated pullback 
was performed to a point >10 mm proximal to the lesion at a 
speed of 0.5 mm/sec. 
Quantitative volumetric grey-scale and VH-IVUS analyses 
were performed across the entire lesion segment, and cross-
sectional analysis was performed at the minimum lumen sites. 
Conventional quantitative volumetric grey-scale IVUS anal-
ysis was performed according to the American College of 
Cardiology Clinical Expert Consensus Document on Stan-
dards for Acquisition, Measurement and Reporting of Intra-
vascular Ultrasound Studies.
14) External elastic membrane 
(EEM) and lumen cross-sectional areas (CSAs) were measur-
ed. Plaque plus media (P&M) CSA was calculated as EEM 
minus lumen CSA. Plaque burden was calculated as P&M 
divided by EEM CSA. Proximal and distal references were the 
single slices with the largest lumen and smallest plaque bur-
den within 10 mm proximally and distally, but before any lar-
ge side branch. VH-IVUS analysis classified color-coded tis-
sue into four major components: green (fibrotic); yellow-gre-
en (fibro-fatty); white (dense calcium); and red (necrotic core, 
NC) (Fig. 1).
11)15) VH-IVUS analysis was reported in abso-
lute quantity, and as a percentage of the plaque area or volume. 
TCFA was defined as NC ≥10% of plaque area in at least 3 
consecutive frames without overlying fibrous tissue, in the 
presence of ≥40% plaque burden.
11)
Statistical analysis 
The Statistical Package for the Social Sciences (SPSS) for 
Windows, version 15.0 (Chicago, IL, USA) was used for all an-
alyses. Continuous variables were presented as mean±SD; 442   C-Reactive Protein and Plaque Components
comparisons were conducted by Student’s t-test or the Wil-
coxon rank-sum test if normality assumption was violated. 
Discrete variables were presented as percentages and frequ-
encies. Comparisons were conducted by chi-square statistics 
or Fisher’s exact test as appropriate. Multivariable analysis 
was performed to identify independent predictors of hs-
CRP elevation (≥0.4 mg/dL), and culprit lesion TCFA. A p< 
0.05 was considered statistically significant.
Results
Patient characteristics
Patient baseline characteristics are summarized in Table 1. 
Mean hs-CRP levels were 0.04 mg/dL in lowest tertile group, 
0.19 mg/dL in middle tertile group, and 1.85 mg/dL in high-
est tertile group. Ejection fraction was lowest, N-terminal pro-
B-type natriuretic peptide, white blood cell count, glucose, 
low-density lipoprotein cholesterol, and triglyceride levels 
were highest, hemoglobin level was lowest, and CK-MB and 
Fig. 1. The example of virtual histology-intravascular ultrasound 
image. 
Table 1. Baseline characteristics
Lowest tertile (n=93) Middle tertile (n=93) Highest tertile (n=93) p 
hs-CRP (mg/dL) 0.04±0.02 0.19±0.09 1.85±2.59 <0.001
Age (years) 62±10 60±12 58±13 <0.060
Male gender (%) 61 (66) 69 (74) 64 (69) <0.4
Clinical presentation (%) <0.7
Unstable angina 45 (48) 40 (43) 37 (40)
NSTEMI 26 (28) 28 (30) 26 (28)
STEMI 22 (24) 25 (27) 30 (32)
Diabetes mellitus (%) 19 (20) 25 (27) 37 (40) <0.003
Hypertension (%) 73 (79) 76 (82) 79 (85) <0.5
Smoking (%) 37 (40) 39 (42) 35 (38) <0.8
Family history of coronary artery disease (%) 5 (5) 3 (3) 2 (2) <0.5
Prior MI (%) 4 (4) 3 (3) 3 (3) <0.9
Ejection fraction (%) 64±70 62±90 59±90 <0.001
NT-pro-BNP (pg/mL) 93±94 229±264 688±769 <0.001
White blood cell (/mm
3) 6324±1376 9401±3399 9491±2818 <0.001
Hemoglobin (g/dL) 13.2±1.70 12.8±1.30 12.2±1.90 <0.001
Platelet count (10
3/mm
3) 225±480 234±570 243±130 <0.4
Creatinine (mg/dL) 0.84±0.18 0.88±0.16 0.87±0.26 <0.4
Glucose (mg/dL) 138±530 134±330 154±540 <0.031
Creatine kinase-MB (U/L) 4.9±1.9 15.2±15.2 27.6±17.6 <0.001
Troponin-I (ng/mL) 0.05±0.14 3.9±6.2 10.8±10.6 <0.001
Total cholesterol (mg/dL) 174±380 186±510 198±340 <0.001
Triglyceride (mg/dL) 95±55 126±890 142±610 <0.001
LDL-C (mg/dL) 113±350 117±430 132±280 <0.001
HDL-C (mg/dL) 49±10 49±13 47±13 <0.6
hs-CRP: high-sensitivity C-reactive protein, NSTEMI: non-ST segment elevation myocardial infarction, STEMI: ST segment elevation myocar-
dial infarction, MI: myocardiol infraction, NT-pro-BNP: N-terminal pro-B-type natriuretic peptide, LDL-C: low density lipoprotein-choles-
terol, HDL-C: high density lipoprotein-cholesterolYoung Joon Hong, et al.   443
Table 2. Coronary angiographic findings
Lowest tertile (n=93) Middle tertile (n=93) Highest tertile (n=93) p 
Culprit lesion, n (%)  0.5
Left anterior descending 60 (65) 56 (60) 63 (68)
Left circumflex 14 (15) 20 (22) 11 (12)
Right 19 (20) 17 (18) 19 (20)
Lesion location, n (%)  0.9
Ostium 5 (5) 4 (4) 3 (3)
Proximal 37 (40) 35 (38) 42 (45)
Middle 28 (30) 33 (36) 28 (30)
Distal 23 (25) 21 (23) 20 (22)
Diseased vessel number, n (%)  0.5
1 56 (60) 51 (55) 47 (51)
2  23 (25) 26 (28) 23 (25)
3 14 (15) 16 (17) 23 (25)
TIMI flow grade, n (%) 0.3
0 2 (2) 4 (4) 6 (7)
1 2 (2) 4 (4) 7 (8)
2  2 (2) 3 (3) 5 (5)
3 87 (94) 82 (89) 75 (81)
Reference diameter (mm) 3.17±0.57 3.02±0.54 3.32±0.56 0.13
MLD (mm) 1.67±0.63 1.21±0.52 1.06±0.61 <0.001
TIMI: Thrombolysis in Myocardial Infarction, MLD: minimal lumen diameter
Table 3. Grey-scale intravascular ultrasound findings
Lowest tertile (n=93) Middle tertile (n=93) Highest tertile (n=93) p 
Proximal reference
    EEM CSA (mm
2) 19.9±6.8 19.0±6.3 21.2±6.8 0.10
    Lumen CSA (mm
2) 12.4±8.0 11.6±6.7 13.1±8.5 0.4
    P&M CSA (mm
2) 07.5±3.5 07.4±2.9 08.1±3.7 0.12
    Plaque burden (%) 37±9 38±8 37±8 0.6
Minimum lumen site
    EEM CSA (mm
2) 16.5±6.5 15.9±5.8 17.8±7.2 0.13
    Lumen CSA (mm
2) 07.2±4.5 06.3±3.5 06.9±3.5 0.3
    P&M CSA (mm
2) 09.3±3.4 09.6±4.2 11.0±5.1 0.020
    Plaque burden (%) 057±13 060±13 061±13 0.18
IVUS lesion length (mm) 018±13 021±12 024±14 0.016
Distal reference
    EEM CSA (mm
2) 16.4±7.3 15.2±6.5 17.5±7.6 0.11
    Lumen CSA (mm
2) 10.3±4.7 09.3±4.1 10.9±4.6 0.075
    P&M CSA (mm
2) 06.1±3.2 05.8±2.7 06.7±3.8 0.2
    Plaque burden (%) 37±8 38±7 37±8 0.5
Volumetric analysis (mm
3)
    EEM volume 0332±245 0405±296 0544±361 0.031
    Lumen volume 0169±110 0201±144 0233±174 0.012
    P&M volume 0163±139 0201±155 0232±176 0.013
EEM: external elastic membrane, CSA: cross-sectional area, P&M: plaque plus media, IVUS: intravascular ultrasound444   C-Reactive Protein and Plaque Components
troponin I levels were highest in the highest tertile group. 
Angiographic findings 
Angiographic findings are summarized in Table 2. There 
were no significant differences in the culprit vessel, lesion lo-
cation, the incidences of multivessel disease, Thrombolysis in 
Myocardial Infarction flow grade, and reference diameter be-
tween three groups. However, minimal lumen diameter was 
smallest in the highest tertile group. 
Grey-scale intravascular ultrasound results
Grey-scale IVUS findings are summarized in Table 3. There 
were no significant differences in the IVUS parameters at 
the proximal and distal references. At the minimum lumen 
sites, P&M CSAs were greatest and IVUS lesion length was 
longest in the highest tertile group. Plaque rupture and mul-
tiple plaque ruptures were observed most frequently in the 
highest tertile group (28% vs. 36% vs. 51%, p<0.001, and 15% 
vs. 22% vs. 30%, p=0.014, respectively). By volumetric analy-
sis, EEM, lumen, and P&M volumes were greatest in the high-
est tertile group.
Virtual histology-intravascular ultrasound results 
At the minimum lumen sites, absolute and %NC areas were 
greatest in the highest tertile group (Fig. 2). By volumetric an-
alysis, absolute and %NC volumes were greatest in the high-
est tertile group (Fig. 3). The TCFA within culprit lesions was 
observed most frequently in the highest tertile group (Fig. 4).
Independent predictors of high-sensitivity C-reactive 
protein elevation and thin-cap fibroatheroma 
Multivariate analysis was performed to identify independent 
predictors of hs-CRP elevation. Variables with p<0.2 in the 
univariate analysis (age, diabetes mellitus, ejection fraction, 
N-terminal pro-B-type natriuretic peptide, white blood cell 
count, hemoglobin, serum glucose, troponin-I, LDL-C, P&M 
volume, IVUS lesion length, volumetric VH-IVUS parame-
ters: absolute FT, DC and NC volumes, relative FF, DC, and 
NC volumes) were evaluated for multivariate analysis. Dia-
betes mellitus {odds ratio (OR): 2.73, 95% confidence interval 
(CI): 1.20-5.42, p=0.009}, N-terminal pro-B-type natriuretic 
peptide (OR; 1.24, 95% CI=1.12-1.36, p=0.008) and absolute 
NC volume (OR; 1.03, 95% CI=1.06-1.21, p=0.004) were in-
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dependent predictors of hs-CRP elevation. 
We performed multivariate analysis to determine indepen-
dent predictors of culprit lesion TCFA. All variables with p< 
0.2 in the univariate analysis (age, male gender, diabetes mel-
litus, hypertension, smoking, ejection fraction, hs-CRP, and 
P&M volume) were evaluated for multivariate analysis. Dia-
betes mellitus (OR: 2.14, 95% CI: 1.30-3.60, p=0.008) and the 
hs-CRP (OR; 1.86, 95% CI=1.11-2.90, p=0.010) were indepen-
dent predictors of TCFA.
 
Discussion
The present VH-IVUS study demonstrated that 1) the hi-
ghest hs-CRP tertile group has the most diabetics, and had 
the greatest P&M volume as well as absolute and % NC vol-
umes; 2) the culprit lesion TCFA was observed most frequ-
ently in the highest hs-CRP tertile group; 3) absolute NC vol-
ume was an independent predictor of hs-CRP elevation; and 
4) the hs-CRP was an independent predictor of TCFA.
CRP has emerged as a simple tool for detecting systemic in-
flammation.
4) An elevated CRP level is associated with in-
creased risk of future fatal or non-fatal ischemic complications 
in ACS patients.
16)17) A previous study demonstrated that CRP 
was strongly associated with atherosclerosis measured at vari-
ous sites in the arterial tree.
18) Several mechanisms have been 
described through which CRP and other inflammatory me-
diators may be actively involved in atherogenesis.
19) CRP is 
produced by smooth muscle cells of atherosclerotic lesions,
20) 
and locally produced CRP could directly participate in athero-
genesis and the development of cardiovascular complications. 
Pathological studies have demonstrated that plaque rupture 
and subsequent thrombosis is the most important mecha-
nism leading to ACS.
21)22) Several grey-scale IVUS studies 
have demonstrated the association between CRP and vul-
nerable plaque in ACS patients.
6)7)10) Sano et al.
6) reported that 
patients with elevated CRP levels had more plaque ruptures, 
compared with those with a normal CRP, and that plaque rup-
ture correlated with elevated CRP level in the setting of AMI. 
Hong et al.
7) reported that elevated CRP level was an indepen-
dent predictor of plaque rupture in AMI patients using a 3- 
vessel IVUS. Tanaka et al.
10) reported that AMI patients with 
culprit lesion plaque ruptures presented with higher CRP le-
vels, as compared with AMI patients without plaque rupture. 
The number of plaque ruptures correlated with CRP levels 
one month from onset. 
VH-IVUS has the potential to provide detailed qualitative 
and quantitative information, and it can help identify four spe-
cific plaque components. Plaque components may play a role 
in plaque disruption and thrombosis that lead to acute coro-
nary events.
23)24) Lesions with a large lipid core may present 
higher risk of disruption than sclerotic plaques.
25)26) TCFA is 
the precursor of plaque rupture, which accounts for a majo-
rity of coronary thrombi and coronary death.
23)27)28) Several 
VH-IVUS studies have reported that ACS patients had more 
NC-containing plaques, and more TCFAs compared with 
stable angina patients.
11)12) Burke et al.
29) reported correlation 
between CRP and the number of TCFAs in patients who ex-
perienced sudden death associated with severe coronary ar-
tery disease. In the present study, the NC component was gr-
eatest, and TCFA within culprit lesions was observed most 
frequently in patients with the highest hs-CRP tertile, and 
there existed a correlation between hs-CRP levels vs. NC com-
ponents and TCFA, and cardiac enzyme levels were signifi-
cantly higher after stenting in patients with TCFA, compar-
ed with patients without TCFA {∆(poststenting-baseline value) 
CK-MB: +10.1±22.0 U/L vs. -3.8±26.1 U/L, p=0.012; ∆cardiac-
specific troponin I: +8.3±15.5 ng/mL vs. -0.9±11.4 ng/mL, p= 
0.021}. The present study suggests that hs-CRP is associated 
with the development of vulnerable plaque in ACS patients. 
The NC components contain foam cells with lipid deposi-
tion, inflammatory cells, intramural bleeding, and cholesterol 
crystals. As such, they may be associated with CRP elevation 
in ACS patients.
There are several limitations to be mentioned. First, the pre-
sent study is a retrospective single-center study and is subject 
to limitations inherent in this type of clinical investigation. Se-
cond, IVUS and VH-IVUS were performed at the discretion 
of individual operators leading to potential selection bias. 
Third, we did not attempt to differentiate between athero-
sclerotic plaque and thrombus, because VH-IVUS could not de-
termine the presence of thrombus. This may obscure the 
identification of TCFA. 
Fourth, heavily calcified plaques may induce an artifact re-
garding the codification of plaques by VH-IVUS, resulting in 
increased NC content. Fifth, serial follow-up of serum hs-CRP 
level was not performed. Therefore, we did not demonstrate 
the impact of sequential change of hs-CRP levels on plaque 
components.
In conclusion, ACS patients with elevated hs-CRP have more 
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vulnerable plaque components (NC-rich plaques and higher 
frequency of culprit lesion TCFA), compared with ACS pa-
tients with normal hs-CRP. 
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